3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
13
Observational
2
Expanded_access
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
1
Interventions
3-Iodobenzylguanidine
6
fluorodopa F 18
2
Ga(III)-DOTATOC
2
surufatinib
1
selpercatinib
1
pegfilgrastim
1
lutetium Lu 177 dotatate
1
gallium Ga 68 dotatate
1
Vorinostat
1
Potassium Iodide
1
Granulocyte Colony-Stimulating Factor
1
Gallium-68
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
surufatinib
×
Endocrine
×
Clear all
NCT04814732
2024-04-12
Expanded Access Program of Surufatinib
Hutchmed
No longer available